The European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) will be hosting the first ever joint Congress on 10-13 May 2025. This truly joint landmark event, ‘Connecting Endocrinology Across the Life Course’, brings together paediatric and adult endocrine specialists from across Europe and the rest of the world to meet, collaborate and celebrate endocrinology at The Bella Centre in Copenhagen, Denmark.

The Congress is expected to attract over 6,000 delegates from over 100 countries to experience the latest endocrine research and developments in both paediatric and adult endocrinology. The event will provide a unique opportunity for learning new perspectives and enabling scientific exchanges, coupled with extensive networking opportunities to make new connections with colleagues working in endocrinology across the whole life course.

The Family Heart Foundation® announces the appointment of Laurence S. Sperling, M.D., FACC, FAHA, FACP, MASPC, as its new Chief Medical Officer (CMO). Dr. Larry Sperling, a renowned leader in preventive cardiology, brings decades of expertise and an extensive history of leadership, research, and public service in heart disease prevention and management. In this role, he will advance the Family Heart Foundation’s innovative research, direct-to-public support, and national advocacy efforts to address the root causes of early atherosclerotic cardiovascular disease (ASCVD) across generations.

Dr. Sperling is the Founder and former Director of The Heart Disease Prevention Center at Emory University and currently serves as the Katz Professor in Preventive Cardiology at Emory University School of Medicine and Professor of Global Health at the Rollins School of Public Health.

As the incoming CMO of the Family Heart Foundation, Dr. Sperling will support the Family Heart Foundation’s real-world data analyses, national CASCADE FH Registry®, centralized family screening program, Flag, Identify, Network, and Deliver (FIND)® initiatives, and educational programming for medical experts and the public on the role of genetically determined cholesterol disorders in causing premature illness and death in millions of Americans.

A new protein supercomplex in mitochondria that enhances energy production, offering potential hope for heart disease patients has been discovered by Duke-NUS scientists.

A multicenter collaboration led by the Bellvitge Biomedical Research Institute (IDIBELL) - Institut Català d'Oncologia (ICO) and the Germans Trias i Pujol Research Institute (IGTP) identified a potential new treatment for an aggressive sarcoma arising in the nerves. The findings have been published in the journal Clinical Cancer Research.

An international team of researchers, led by scientists from Tel Aviv University, has discovered that the pathogen responsible for the mass deaths of sea urchins along the Red Sea coast is the same one responsible for mass mortality events among sea urchins off the coast of Réunion Island in the Indian Ocean. This finding raises fears that the pathogen – a waterborne ciliate - could spread further, to the Pacific Ocean.

Researchers at Linköping University, Sweden, have succeeded in creating a close connection between individual cells and organic electronics. The study, published in Science Advances, lays the foundation for future treatment of neurological and other diseases with very high precision.